Institutional investors purchased a net $88.1 thousand shares of LIFE during the quarter ended September 2016 and now own 37.23% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FEDERATED GLOBAL INVESTMENT MANA... Bought 189.7 Thousand shares of aTyr Pharma Inc
ALYESKA INVESTMENT GROUP LP Bought 89.7 Thousand shares of aTyr Pharma Inc
JACOBS LEVY EQUITY MANAGEMENT, I... Bought 88.6 Thousand shares of aTyr Pharma Inc